- Home
- CADL vs LAES Comparison
CADL vs LAES Comparison
Compare CADL & LAES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CADL | LAES |
|---|---|---|
| Founded | 1999 | 2022 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 366.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CADL | LAES |
|---|---|---|
| Price | $5.67 | $3.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $19.43 | $6.50 |
| AVG Volume (30 Days) | 976.9K | ★ 9.7M |
| Earning Date | 11-13-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $10,978,000.00 |
| Revenue This Year | N/A | $66.73 |
| Revenue Next Year | N/A | $92.76 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.25 | $1.99 |
| 52 Week High | $13.68 | $9.50 |
Technical Indicators
Market Signals| Indicator | CADL | LAES |
|---|---|---|
| Relative Strength Index (RSI) | 52.75 | 40.26 |
| Support Level | $5.45 | $3.83 |
| Resistance Level | $6.14 | $4.76 |
| Average True Range (ATR) | 0.40 | 0.32 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 16.73 | 2.83 |
Price Performance
Historical ComparisonAbout CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.